In addition, ADT or AR blockade would reduce the levels of GNMT, leading to increased SAM/SAH ratios and methyltransferase activity, a condition that maybe conducive to aggressive PCa (i.e., increased EZH2 levels in CRPC [78,191,193]). The gene discussed is GNMT; the disease is posterior cortical atrophy.